TranscriptsOct 19, 2026, 3:53 PM ETDisc Medicine, Inc. (IRON) StockSA Transcripts162.5K FollowersDisc Medicine, Inc. (IRON) Discusses Topline Results of APOLLO Phase III Trial of Bitopertin in EPP October 19, 2026 8:00 AM EDTCompany ParticipantsJohn Quisel - CEO, President & DirectorWilliam Savage - Chief Medical OfficerPamela Stephenson - Chief Commercial OfficerJean Franchi - Chief Financial OfficerConference Call ParticipantsJiale Song - Jefferies LLC, Research DivisionThomas Smith - Leerink Partners LLC, Research DivisionKristen Kluska - Cantor Fitzgerald & Co., Research DivisionSean Laaman - Morgan Stanley, Research DivisionTara Bancroft - TD Cowen, Research DivisionEvan Seigerman - BMO Capital Markets Equity ResearchDerek Archila - Wells Fargo Securities, LLC, Research DivisionDouglas Tsao - H.C. Wainwright & Co, LLC, Research DivisionRami Katkhuda - LifeSci Capital, LLC, Research DivisionDavid Nierengarten - Wedbush Securities Inc., Research DivisionMartin Auster - Raymond James & Associates, Inc., Research DivisionStephen Willey - Stifel, Nicolaus & Company, Incorporated, Research DivisionDanielle Brill Bongero - Truist Securities, Inc., Research DivisionPresentationOperatorGood day, and thank you for standing by. Welcome to the Disc Medicine Corporate Call. [Operator Instructions] Please be advised that today's conference is being recorded.I would now like to hand the conference over to your speaker today, John Quisel. Sir, please go ahead.John QuiselCEO, President & DirectorThank you. Good morning, and welcome, everyone. This is John Quisel speaking, CEO of Disc Medicine. And I'll be joined today by Will Savage, our Chief Medical Officer, and Pamela Stephenson, our Chief Commercial Officer.And we're here to review the topline results for the APOLLO Phase 3 trial of bitopertin in erythropoietic protoporphyria or EPP.Before we get started, a few preliminaries, I'd like to remind everyone that we will be making forward-looking statements, and these should be taken in context with respect to materials that we have filed with the SEC and have posted on our website.Read more current IRON analysis and newsView all earnings call transcriptsComments